Treatment of Relapsed/Refractory Myeloma (excluding T-cell redirection therapy)
Characteristics, Treatment and Outcome of Patients with Extramedullary Multiple Myeloma or Plasma Cell Leukemia: A Real-World Monocentric Analysis
Christoph Schaefers
MD
University Medical Center Hamburg-Eppendorf, Germany